Diabetes mellitus and thyroid diseases


Authors: Zdenek Schroner 1;  Vladimír Uličiansky 2
Authors‘ workplace: SchronerMED s. r. o., interná a diabetologická ambulancia, Košice 1;  Via medica, s. r. o. Košice 2
Published in: Forum Diab 2014; 3(3): 135-141
Category: Topic

Overview

The prevalence of thyroid diseases in patients with diabetes mellitus is approximately 10- 15% (in non-diabetic population is about 6 %). The relationship between diabetes mellitus type 2 and thyreopathies is complex and not completely researched at present time. Autoimmune thyropathies are frequent in patients with type 1 diabetes mellitus. At present there are some studies demonstrating higher prevalence of autoimmune thyreopathies also in type 2 diabetes mellitus. Chronic autoimmune thyroiditis is the most frequent form of autoimmune thyropathies also in patients with diabetes mellitus. Clinical relevance ot thyroid diseases in patients with DM significantly increa­ses if the thyroid diseases are associated with deteriorated function. Subclinical thyroid dysfunctions are frequent in patients with diabetes mellitus, where belong subclinical hypothyreosis and subclinical hyperthyreosis. Subclinical thyroid dysfunctions in diabetics can lead to higher fluctuations of glycaemias and to deterioration of compensation of diabetes mellitus.

Key words:
diabetes mellitus – mutual relationship – thyreopathies


Sources

1. Volzke H, Kroh U, Wallascchofski H et al. The spectrum of thyroid disorders in adult type 1 diabetes mellitus. Diabetes Metab Res Rev 2007; 23(3): 227–233.

2. Vondra K, Zamarazil V. Onemocnění štítné žlázy u dospělých diabetiků. In: Perušičová J. Trendy soudobé diabetologie. Svazek 9. Galén: Praha 2004. 31–48. ISBN 8072622919.

3. Vondra K, Vrbíková J, Ivašková E et al. Výskyt protilátek proti tyreoglobulínu a proti mikrozomům u dospělých diabetiků 1. typu a jejich možný klinický význam. Vnitř Lék 1996; 42(11): 767–771.

4. Vondra K, Vrbíková J, Šterzl I. Tyreoidální autoimunita u dospělých diabetiků 1. typu. Vlastní zkušenosti z 11letého sledování. Vnitř Lék 2006; 52(10): 864- 872.

5. Mentucia D. Association between a novel variant of the human type 2 deiodinase gene Thr92Ala and insulin resistance: evidence of interaction with the Trp64Arg variant of the beta-adrenergic receptor. Diabetes 2002, 51(3): 880–883.

6. Límanová Z. Choroby štítné žlázy. In: Klener P et al. Vnitřní lékařství. 2nd ed. Galén: Praha 2001. 763–777. ISBN 8072621017.

7. Perros P, McCrimon RJ, Shaw G et al. Frequency of thyroid dysfunction in diabetic patients: value of annual screening. Diabet Med 1995; 12(7): 622–627.

8. Zamrazil V, Vondra K. Štítná žľáza a diabetes. In: Bartoš V, Pelikánová T. Praktická diabetologie.4th ed. Maxdorf: Praha 2010. 625–640. ISBN 978–80–7345–216–2.

9. Tahirovic H, Ducic V et.al. Euthyroid sick syndrome in type I diabetes mellitus in children and adolescents. Acta Paedr Hung 1991; 31(1): 67–73.

10. Krotkiewski M. Thyroid hormones and treatment of obesity. Int J Obes Relat Metab Disord 2000, 24(Suppl 2): 116–119.

11. Vondra K, Zamrazil V. Endokrinní systém a diabetes mellitus. In: Blahoš J, Zamrazil V. Endokrinologie interdisciplinární obor. Triton: Praha 2006: 353–366. ISBN 80–7254–788–7.

12. Žákovičová E, Zamrazil V jr. Vliv endokrinních onemocnení na kompenzaci diabetes mellitus, sekundární diabetes melitus. Postgaduální medicína 2009; 4(11): 446–450.

13. Pearce SHS, Merriman TR. Genetics of type 1 diabetes and autoimmune thyroid disease. Endocrinol Metab Clin N Am 2009; 38(2): 289–301.

14. Santamaria P, Barbosa JJ, Lindstrom AL et al. HLA DQB1-associated susceptiblity that distinguishes Hashimoto`s disease in type 1 diabetic patients. J Clin Endocrinol Metab 1994; 78(4): 878–883.

15. Donner H, Rau H, Walfish PG et al. CTLA 4 alanine –17 confers genetic susceptiblity to Graves´disease and type 1. diabetes mellitus. J Clin Endocrinol Metab 1997; 82(1): 143–146.

16. Vaidya B, Paarce S. The emerging role of CTLA-4 gene in autoimmune endocrinopathies. Eur J Endocrinol 2004; 150(5): 619–626.

17. Diez JJ, Sanchez P, Iglesias P. Prevalence of thyroid dysfunction in patiens with type 2 diabetes. Exp Clin Endocrinol Diabetes 2011; 119(4): 201–207.

18. Bianco AC, Kim BW. Deiodinases:implications of the local control of thyroid hormone action. J Clin Invest 2006; 16(10): 2571–2579.

19. Canani LH. The type 2 deiodinase A/G (Thr92Ala) polymorphism is associated with decreased velocity and increased resitance in patiensts with type 2 diabetes mellitus. J Clin Endocrinol Metab 2005; 90(6): 3472–3478.

20. Lambadiari V, Mitoru P, Maratou E et al. Thyroid hormones are positively associated with insulin resistance early in the development of type 2 diabetes. Endocrine 2011; 39(1): 28–32.

21. Mentucia D. Association between a novel variant of the human type 2 deiodinase gene Thr92Ala and insulin resistance:evidence of interaction with the Trp64Arg variant of the beta-adrenergic receptor. Diabetes 2002; 51(3): 880–883.

22. Dora JM, Machado WE, Rheinheimer J et al. Association of the type 2 deiodinase Thr92ALA polymorphis with the type 2 diabetes: case control study and meta-analysis. Europ J Endocrinol 2010; 163(3): 427–434.

23. Estivalet A. DII Thr92Ala and PPARγ 2 Pro12Ala polymorhism interact in the modulation of insulin resistance in type 2 diabetic patients. Obesity (Silver Spring) 2011; 19(4): 825–832.

24. Kiňová S, Payer J, Kalafutová I et al. Výskyt autoimunitnej tyreopatie u pacientov s diabetes mellitus 1. typu. Bratisl Lek Listy 1998; 99(1): 23–25.

25. Akawaza S, Kawasaki E et.al. Autoantibodies to glutamic acid decarboxylase (GAD), 64,000-Mr islet cell protein (64K) antibodies and islet cell antibodies (ICA) in insulin–dependent diabetes mellitus with and without autoimmune disease in Japan. Diabetes Res Clin Pract 1994; 24(Suppl): S89- S93.

26. Límanová Z, Jiskra J. Autoimunitní tyreopatie-královna endokrinných syndromu. DMEV 2004; 7(Suppl2): 32–35.

27. Límanová Z, Němec J, Zamrazil V. Nemoci štítné žlázy. Galén: Praha 1995. ISBN 80–85824–25–6.

28. Límanová Z, Zamarazil V. Má být zaveden screening funkčních tyreoidálnych onemocnění u dospělých v České republice? DMEV 2004; 7: 124–129.

29. Anděl M, Kraml P, Potočková J et al. The differences between type 2. and LADA (Type 1.) diabetic patients of same age. Diabetes Res Clin Pract 2000; 50(Suppl 1): 113.

30. Běhanová-Matějková M. Latent autoimmune diabetes in adults (LADA) and autoimmune thyroiditis. Endocr Regul 2001; 35(3): 167–172.

31. Běhanová-Matějková M, Zamrazil V et al. Middle aged Onset type 1 diabetes: differences among individuals with and without autoimmune thyroiditis. Diabetologia 2000; 43(Suppl 1): A110.

32. Kawasaki E, Takino H et.al. Autoantibodies to glutamic acid decarboxylase in patients with IDDM and autoimmune thyroid disease. Diabetes 1994; 43(1): 80–86.

33. Krejčí H, Perušičová J. Autoimunitní tyreopatie u diabetes mellitus 1. a 2. typu. DMEV 2004; 7(3). Abstr 164.

34. McCanlies E, Oleary LA, Foley TF et al. Hashimoto´s thyroiditis and insulin dependent diabetes mellitus: differences among individuals with and without abnormal thyroid function. J Clin Endocrinol Metab 1998; 83(5): 1548–1551.

35. Dorman J, Kramer MK, O‘Lear LA et al. Molecular epidemiology of autoimmune thyroid disease. Gac Med Mex 1997; 133(Suppl 1): 97–103.

36. Wartofsky. Diseases of the Thyroid. In: Fauci AS. et al. Harrison´s Principles of Internal Medicine 14th edition. 2012–2035. McGraw-Hill: 1997. ISBN 13: 978–0070202924.

37. Wilson JD et al. William´s textbook of endocrinology. 9th ed. W.B. Saunders: 1998. ISBN 978–0721661520.

38. Vondra K, Zamarazil V. Onemocnění štítné žlázy u nemocných s diabetes mellitus. DMEV 2002; 5(2): 78–84.

39. Vrbíková J, Vondra K, Matys Z. Autoimunitní orgánově specifická oněmocnení u pacientu s autoimunitním diabetem mellitem. In: Stárka L et al. Aktuální endokrinologie. Maxdorf: Praha 1999. 634–639. ISBN 9788085912104.

40. Kalmann R, Mourits MP. Diabetes mellitus: a risk factor in patients with Graves orbithopathy. Br J Ophthalmol 1999; 83(4): 463–465.

41. Dvořáková M, Němec J. Poruchy štítné žlázy, těhotenství a vývoj plodu. In: Stárka L et al. Aktuální endokrinologie. Maxdorf: Praha 1999: 405–415. ISBN 9788085912104.

42. Fernadez-Soto L, Gonzales A, Lobon et al. Thyroid peroxidase autoantibodies predict poor metabolic control and need for thyroid treatment in pregnant IDDM women. Diabetes Care 1997; 20(10): 1524–1528.

43. Hauerová D, Pikner R et al. Tyreopatie u těhotných žen a jejich vývoj po porodu. Vnitř Lék 2002; 48(11): 1060–1064.

44. Hauerová D, Topolčan O et al. Poruchy štítné žlázy v gravidite a jejich léčba. DMEV 2003; 6(4): 200–203.

45. Drbalová K, Herdová K, Pačesová M et al. Subklinické tyreopatie. Vnitř Lék 2006; 52(10): 963- 968.

46. Ayala A, Wartofsky L. Minimally symptomatic (subclinical) hypothyroidism. The Endocrinologist 1997; 7: 44–50.

47. Mohn A, Di-Michelle S et al. The effect of subclinical hypothyroidism on metabolic control in children and adolescents with type 1 diabetes mellitus. Diabet Med 2002; 19(1): 70–73.

48. Hak AE, Pols HAP et al. Subclinical hypothyroidism is an independent risk factor for atherosclerosis and myocardial infarction in elderly women: The Rotterdam Study. Ann Int Med 2000; 132(4): 270–278.

49. Bakker SJ, ter Maaten JC, Popp-Snijders C et al. The relationship between thyrotropin and low density lipoprotein cholesterol is modified by insulin sensitivity in healthy euthyroid subjects. J Clin Endocrinol Metab 2001; 86(3): 1206–1211.

50. Komiya I, Takasu N, Yamada T et al. Studies on the association of NIDDM in Japanese patients with hyperthyroid Grave`s disease. Horm Res 1992; 38(5–6): 264–268.

51. Zamrazil V, Němec J. Vliv amiodaronu na štítnou žlázu. In: Stárka L et.al. Aktuální endokrinologie. Maxdorf: Praha 1999: 415–424. ISBN 80–85912–10–4.

52. Paul DT, Mollah FH et al. Glycemic status in hyperthyroid subjects. Mymensingh Med J 2004; 13(1): 71–75.

53. Schroner Z, Lazúrová I, Petrovičová J. Autoimuniutné tyreopatie u diabetikov. Vnitř lek 2006; 52(2): 137–143.

54. Ober K. Polyendocrine syndromes. In: Leahy J, Clark N, Cafalu W. Medical Management of Diabetes Mellitus. Marcel Dekker, New York 2000: 699–717.

Labels
Diabetology Endocrinology Internal medicine
Login
Forgotten password

Don‘t have an account?  Create new account

Forgotten password

Enter the email address that you registered with. We will send you instructions on how to set a new password.

Login

Don‘t have an account?  Create new account